File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3389/fphar.2022.928817
- Scopus: eid_2-s2.0-85135212494
- PMID: 35928282
- WOS: WOS:000835106200001
Supplementary
- Citations:
- Appears in Collections:
Article: An Update on the Potential Application of Herbal Medicine in Promoting Angiogenesis
Title | An Update on the Potential Application of Herbal Medicine in Promoting Angiogenesis |
---|---|
Authors | |
Keywords | herbal medicine ischemic diseases phytochemicals pro-angiogenic wound healing |
Issue Date | 2022 |
Citation | Frontiers in Pharmacology, 2022, v. 13, article no. 928817 How to Cite? |
Abstract | Angiogenesis, the formation of new capillaries from pre-existing vascular networks, plays an important role in many physiological and pathological processes. The use of pro-angiogenic agents has been proposed as an attractive approach for promoting wound healing and treating vascular insufficiency-related problems, such as ischemic heart disease and stroke, which are the leading causes of death worldwide. Traditional herbal medicine has a long history; however, there is still a need for more in-depth studies and evidence-based confirmation from controlled and validated trials. Many in vitro and in vivo studies have reported that herbal medicines and their bioactive ingredients exert pro-angiogenic activity. The most frequently studied pro-angiogenic phytochemicals include ginsenosides from Panax notoginseng, astragalosides and calycosin from Radix Astragali, salvianolic acid B from Salvia miltiorrhiza, paeoniflorin from Radix Paeoniae, ilexsaponin A1 from Ilex pubescens, ferulic acid from Angelica sinensis, and puerarin from Radix puerariae. This review summarizes the progress in research on these phytochemicals, particularly those related to pro-angiogenic mechanisms and applications in ischemic diseases, tissue repair, and wound healing. In addition, an outline of their limitations and challenges during drug development is presented. |
Persistent Identifier | http://hdl.handle.net/10722/315485 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, J | - |
dc.contributor.author | LI, R | - |
dc.contributor.author | Wu, X | - |
dc.contributor.author | ZHENG, C | - |
dc.contributor.author | Shiu, HT | - |
dc.contributor.author | Rangsinth, P | - |
dc.contributor.author | Lee, SMY | - |
dc.contributor.author | Leung, GPH | - |
dc.date.accessioned | 2022-08-19T08:58:47Z | - |
dc.date.available | 2022-08-19T08:58:47Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Frontiers in Pharmacology, 2022, v. 13, article no. 928817 | - |
dc.identifier.uri | http://hdl.handle.net/10722/315485 | - |
dc.description.abstract | Angiogenesis, the formation of new capillaries from pre-existing vascular networks, plays an important role in many physiological and pathological processes. The use of pro-angiogenic agents has been proposed as an attractive approach for promoting wound healing and treating vascular insufficiency-related problems, such as ischemic heart disease and stroke, which are the leading causes of death worldwide. Traditional herbal medicine has a long history; however, there is still a need for more in-depth studies and evidence-based confirmation from controlled and validated trials. Many in vitro and in vivo studies have reported that herbal medicines and their bioactive ingredients exert pro-angiogenic activity. The most frequently studied pro-angiogenic phytochemicals include ginsenosides from Panax notoginseng, astragalosides and calycosin from Radix Astragali, salvianolic acid B from Salvia miltiorrhiza, paeoniflorin from Radix Paeoniae, ilexsaponin A1 from Ilex pubescens, ferulic acid from Angelica sinensis, and puerarin from Radix puerariae. This review summarizes the progress in research on these phytochemicals, particularly those related to pro-angiogenic mechanisms and applications in ischemic diseases, tissue repair, and wound healing. In addition, an outline of their limitations and challenges during drug development is presented. | - |
dc.language | eng | - |
dc.relation.ispartof | Frontiers in Pharmacology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | herbal medicine | - |
dc.subject | ischemic diseases | - |
dc.subject | phytochemicals | - |
dc.subject | pro-angiogenic | - |
dc.subject | wound healing | - |
dc.title | An Update on the Potential Application of Herbal Medicine in Promoting Angiogenesis | - |
dc.type | Article | - |
dc.identifier.email | Wu, X: raxpwu@hku.hk | - |
dc.identifier.email | Shiu, HT: polly55@hku.hk | - |
dc.identifier.email | Rangsinth, P: ptkrs@hku.hk | - |
dc.identifier.email | Leung, GPH: gphleung@hkucc.hku.hk | - |
dc.identifier.authority | Leung, GPH=rp00234 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3389/fphar.2022.928817 | - |
dc.identifier.pmid | 35928282 | - |
dc.identifier.pmcid | PMC9345329 | - |
dc.identifier.scopus | eid_2-s2.0-85135212494 | - |
dc.identifier.hkuros | 336089 | - |
dc.identifier.volume | 13 | - |
dc.identifier.spage | article no. 928817 | - |
dc.identifier.epage | article no. 928817 | - |
dc.identifier.isi | WOS:000835106200001 | - |